Entera Health, Inc. announced today that the number of patients enrolled into a study to evaluate the impact of EnteraGam, a serum-derived bovine immunoglobulin/ protein isolate , on HIV-associated enteropathy has surpassed the midpoint of recruitment.
http://www.freshnews.com/news/869872/correcting-and-replacing-entera-health-provides-update-recruitment-hiv-enteropathy-tria
http://www.freshnews.com/news/869872/correcting-and-replacing-entera-health-provides-update-recruitment-hiv-enteropathy-tria
No comments:
Post a Comment